Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunizations”

1,105 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,105 results

Not applicableStudy completedNCT03973905
What this trial is testing

Effectiveness of Maternal Immunization With Boostrix at Preventing Pertussis Among Infants <2 Months Old in the United States

Who this might be right for
Whooping Cough
GlaxoSmithKline 290
Testing effectiveness (Phase 2)Study completedNCT03334695
What this trial is testing

An Exploratory Study to Evaluate the Prophylactic Efficacy of a Single Immunization of Ad26.RSV.preF Against Respiratory Syncytial Virus Infection in a Virus Challenge Model in Healthy 18 to 50 Year-old Adults

Who this might be right for
Healthy
Janssen Vaccines & Prevention B.V. 64
Not applicableNot Yet RecruitingNCT07282795
What this trial is testing

Post-marketing Surveillance Study for the Safety of Efluelda® Pre-filled Syringe

Who this might be right for
Influenza ImmunizationHealthy Volunteers
Sanofi 670
Not applicableWithdrawnNCT03609372
What this trial is testing

The STOP-HPV Trial 6: Single Arm Evaluation of the Maintenance of the STOP-HPV Bundle

Who this might be right for
VaccinationImmunization
University of California, Los Angeles
Large-scale testing (Phase 3)Study completedNCT04754594
What this trial is testing

To Evaluate the Safety, Tolerability, and Immunogenicity of BNT162b2 Against COVID-19 in Healthy Pregnant Women 18 Years of Age and Older

Who this might be right for
SARS-CoV-2 InfectionCOVID-19Maternal Immunization
BioNTech SE 726
Testing effectiveness (Phase 2)Looking for participantsNCT07759856
What this trial is testing

NK Cells Plus ICI for SCLC Maintenance

Who this might be right for
Small Cell Lung Cancer
Tianjin First Central Hospital 42
Early research (Phase 1)Study completedNCT03583606
What this trial is testing

A Trial to Evaluate the Safety and Systems Biology Response of Ebolavirus Zaire Vaccine (ChAd3-EBO-Z)

Who this might be right for
Ebola DiseaseImmunisation
National Institute of Allergy and Infectious Diseases (NIAID) 61
Not applicableLooking for participantsNCT07130799
What this trial is testing

Innate Immune Response Monitoring Via Monocyte HLA-DR in Severe Intra-abdominal Infections at Risk of Fungal Infection

Who this might be right for
Intra-abdominal InfectionCritical IllnessPost-Op Infection+2 more
Central Hospital, Nancy, France 100
Not applicableStudy completedNCT02983487
What this trial is testing

Pertussis Immunization Programs in Low Income Countries

Who this might be right for
Bordetella Pertussis, Whooping Cough
Institut Pasteur 3,587
Testing effectiveness (Phase 2)Study completedNCT02301702
What this trial is testing

Maternal Tdap Immunization in Guatemala

Who this might be right for
PertussisWhooping Cough
Emory University 286
Large-scale testing (Phase 3)Study completedNCT00944034
What this trial is testing

Safety, Tolerability and Immunogenicity of Meningococcal B Recombinant Vaccine Administered as Booster Dose at 12, 18 or 24 Months of Age in Toddlers (12-24 Months) Primed With a Three-Dose Immunization Series as Infants in Study V72P12

Who this might be right for
Meningococcal DiseaseMeningococcal Meningitis
Novartis Vaccines 1,588
Large-scale testing (Phase 3)Study completedNCT04368429
What this trial is testing

Study of a Quadrivalent Meningococcal Conjugate Vaccine as a Single Dose Compared With a Single Dose of a Meningococcal Reference Vaccine in Children, Adolescents, and Adults 2 to 55 Years of Age

Who this might be right for
Meningococcal Immunisation (Healthy Volunteers)
Sanofi 360
Post-approval studies (Phase 4)Active Not RecruitingNCT06825312
What this trial is testing

Immunogenicity, Safety, and Antibody Persistence of Different Immunization Strategies Against Japanese Encephalitis

Who this might be right for
Japanese Encephalitis Vaccine
Liaoning Chengda Biotechnology CO., LTD 600
Testing effectiveness (Phase 2)Study completedNCT00150111
What this trial is testing

Rituximab in the Treatment of Graves' Disease

Who this might be right for
Graves´ DiseaseThyroid Associated Ophthalmopathy
Odense University Hospital 20
Post-approval studies (Phase 4)UnknownNCT05373030
What this trial is testing

Sequential Immunization With Recombinant Adenovirus Type-5-vectored COVID-19 Vaccine in Health Adults Based on 3 Doses Inactivated COVID-19 Vaccine

Who this might be right for
Immunogenicity and Safety of a Recombinant Adenovirus Type-5-vectored COVID-19 Vaccine Using for Sequential Immunization
Zhejiang Provincial Center for Disease Control and Prevention 200
Not applicableLooking for participantsNCT07171164
What this trial is testing

Evaluate Community-Based Measures to Increase RSV Vaccine Use Among Latino Adults

Who this might be right for
Older Adults Without Any Specific Clinical ConditionSocial NetworksRSV Immunization+1 more
University of California, San Francisco 750
Early research (Phase 1)Study completedNCT00019175
What this trial is testing

Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Recurrent Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
National Cancer Institute (NCI)
Large-scale testing (Phase 3)Study completedNCT01917357
What this trial is testing

A Comparison of the Immunogenicity and Safety of Quinvaxem in Mono-dose Vials and Uniject

Who this might be right for
DiphtheriaPertussisTetanus+2 more
Crucell Holland BV 400
Large-scale testing (Phase 3)Ended earlyNCT04348656
What this trial is testing

CONvalescent Plasma for Hospitalized Adults With COVID-19 Respiratory Illness (CONCOR-1)

Who this might be right for
COVID-19
Hamilton Health Sciences Corporation 940
Testing effectiveness (Phase 2)Ended earlyNCT00612222
What this trial is testing

Anti-MART-1 F5 Cells Plus ALVAC MART-1 Vaccine to Treat Advanced Melanoma

Who this might be right for
Metastatic MelanomaSkin Cancer
National Cancer Institute (NCI) 4
Next Page